Kintara Therapeutics Announces Fiscal 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 27, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal year ended June 30, 2022 and…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.